Biosafety in dairy farming has become an essential aspect of modern agricultural practices, as infectious diseases can severely impact animal health, milk production, and overall profitability. With ...
Medicine shortages, preventive care, and mental health reform top priority list of new Belgian government says Health Minister Vandenbroucke.
Discover the flu recovery diet doctors don’t mention. Boost your immune system with the right foods and recover faster with science-backed nutrition.
Pharmaceutical Technology on MSN18h
FDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
Developed by CSIR’s National Institute for Interdisciplinary Science and Technology (NIIST), the "Sṝrjanam" rig represents a ...
Addresses the significant threat of antimicrobial resistance.
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
Researchers in Australia have pinpointed a protein found in oysters as a way to make antibiotics more effective. As ...
The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.
It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.
AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback